#ITI#Expression of infectious laryngotracheitis virus glycoproteins in Escherichia coli and their application in enzyme-linked immunosorbent assay#FTI#
#IRE#Three glycoproteins of infectious laryngotracheitis virus (ILTV), gC, gE, and gp60, were expressed in Escherichia coli as fusion proteins with a 6-histidine tag at their amino termini. The proteins expressed, designated as r-gC, r-gp60, and r-gE, all retain their antigenicity, as revealed by Western blot with chicken antiserum against ILTV. However, only r-gp60 and r-gE, but not r-gC, were found to be soluble. The soluble r-gp60 and r-gE were purified by a nickel column and then used as the enzyme-linked immunosorbent assay (ELISA) antigen for detecting ILTV-specific antibodies. The diagnostic potential of r-gE and r-gp60 ELISA was assessed with the use of sera prepared from vaccinated or unvaccinated chickens of either specific-pathogen-free (SPF) or field origins. The result shows that r-gp60 and r-gE ELISA could discriminate vaccinated SPF chickens from unvaccinated ones 2 wk postvaccination. Moreover, r-gp60 and r-gE ELISA could also discriminate vaccinated field flocks from unvaccinated ones. This result indicates that r-gp60 and r-gE might serve as an alternative ELISA antigen for detecting ILTV-specific antibodies. Moreover, r-gp60 or r-gE ELISA might play an important role in the eradication of infectious laryngotracheitis (ILT) in the future when the gp60- or gE-deleted marker vaccine of ILT is available.#FRE#
#IPC#ELISA; Enzyme-linked immunosorbent assay; Escherichia coli; Glycoprotein; ILTV; Infectious laryngotracheitis virus#FPC#
#IRF#Anderson D.A., Li F., Riddell M., Howard T., Seow H.F., Torresi J., Perry G., Sumarsidi D., Shrestha S.M., Shrestha I.L., ELISA for IgG-class antibody to hepatitis E virus based on a highly conserved, conformational epitope expressed in Escherichia coli, J. Virol. Methods, 81, pp. 131-142, (1999); 
Bagust T.J., Guy J.S., Laryngotracheitis, Disease of poultry, 10th ed., pp. 527-539, (1997); 
Barajas-Rojas J.A., Riemann H.P., Franti C.E., Notes about determining the cut-off value in enzyme-linked immunosorbent assay (ELISA), Prev. Vet. Med., 15, pp. 231-233, (1993); 
Boshoff C.H., Dungu B., Williams R., Vorster J., Conradie J.D., Verwoerd D.W., York D.F., Detection of Maedi-Visna virus antibodies using a single fusion transmembrane-core p25 recombinant protein ELISA and a modified receiver-operating characteristic analysis to determine cut-off values, J. Virol. Methods, 63, pp. 47-56, (1997); 
Chang P.C., Lee Y.L., Shien J.H., Shieh H.K., Rapid differentiation of vaccine strains and field isolates of infectious laryngotracheitis virus by restriction fragment length polymorphism of PCR products, J. Virol. Methods, 66, pp. 179-186, (1997); 
Crabb B.S., MacPherson C.M., Reubel G.H., Browning G.F., Studdert M.J., Drummer H.E., A type-specific serological test to distinguish antibodies to equine herpesviruses 4 and 1, Arch. Virol., 140, pp. 245-258, (1995); 
Crabb B.S., Studdert M.J., Expression of small regions of equine herpesvirus 1 glycoprotein C in Escherichia coli, Vet. Microbiol., 46, pp. 181-191, (1995); 
De Diego M., Brocchi E., Mackay D., De Simone F., The non-structural polyprotein 3 ABC of foot-and-mouth disease virus as a diagnostic antigen in ELISA to differentiate infected from vaccinated cattle, Arch. Virol., 142, pp. 2021-2033, (1997); 
Fuchs W., Mettenleiter T.C., DNA sequence and transcriptional analysis of the UL1 to UL5 gene cluster of infectious laryngotracheitis virus, J. Gen. Virol., 77, pp. 2221-2229, (1996); 
Fuchs W., Mettenleiter T.C., DNA sequence of the UL6 to UL20 genes of infectious laryngotracheitis virus and characterization of the UL10 gene product as a nonglycosylated and non-essential virion protein, J. Gen. Virol., 80, pp. 2173-2182, (1999); 
Griffin A.M., The nucleotide sequence of the glycoprotein gB gene of infectious laryngotracheitis virus: Analysis and evolutionary relationship to the homologous gene from other herpesviruses, J. Gen. Virol., 72, pp. 393-398, (1991); 
Guo P., Scholz E., Maloney B., Welniak E., Construction of recombinant avian infectious laryngotracheitis virus expressing the beta-galactosidase gene and DNA sequencing of the insertion region, Virology, 202, pp. 771-781, (1994); 
Guy J.S., Barnes H.J., Smith L., Increased virulence of modified-live infectious laryngotracheitis vaccine virus following bird-to-bird passage, Avian Dis., 35, pp. 348-355, (1991); 
Hughes C.S., Williams R.A., Gaskell R.M., Jordan F.T., Bradbury J.M., Bennett M., Jones R.C., Latency and reactivation of infectious laryngotracheitis vaccine virus, Arch. Virol., 121, pp. 213-218, (1991); 
Johnson M.A., Prideaux C.T., Kongsuwan K., Sheppard M., Fahey K.J., Gallid herpesvirus 1 (infectious laryngotracheitis virus): Cloning and physical maps of the SA-2 strain, Arch. Virol., 119, pp. 181-198, (1991); 
Johnson M.A., Prideaux C.T., Kongsuwan K., Tyack S.G., Sheppard M., ICP27 immediate early gene, glycoprotein K (gK) and DNA helicase homologues of infectious laryngotracheitis virus (gallid herpesvirus 1) SA-2 strain, Arch. Virol., 140, pp. 623-634, (1995); 
Kakkanas A., Papadogeorgaki H., Manservigi R., Miriagou V., Georgopoulou U., Mavromara P., Escherichia coli expressed herpes simplex virus gG1 and gG2 proteins in ELISA and immunoblotting assays, Intervirology, 38, pp. 346-351, (1995); 
Kingsley D.H., Hazel J.W., Keeler C.L. Jr., Identification and characterization of the infectious laryngotracheitis virus glycoprotein C gene, Virology, 203, pp. 336-343, (1994); 
Kit S., Kit M., McConnell S., Lawhorn B., Development of active immunity in newborn pigs with colostral antibodies by vaccination with gIII-deleted PRV, Acta Vet. Hung., 42, pp. 319-330, (1994); 
Kit S., Sheppard M., Ichimura H., Kit M., Second-generation pseudorabies virus vaccine with deletions in thymidine kinase and glycoprotein genes, Am. J. Vet. Res., 48, pp. 780-793, (1987); 
Kongsuwan K., Johnson M.A., Prideaux C.T., Sheppard M., Identification of an infectious laryngotracheitis virus gene encoding an immunogenic protein with a predicted M(r) of 32 kilodaltons, Virus Res., 29, pp. 125-140, (1993); 
Kongsuwan K., Johnson M.A., Prideaux C.T., Sheppard M., Use of lambda gt11 and monoclonal antibodies to map the gene for the 60,000 dalton glycoprotein of infectious laryngotracheitis virus, Virus Genes, 7, pp. 297-303, (1993); 
Kongsuwan K., Prideaux C.T., Johnson M.A., Sheppard M., Fahey K.J., Nucleotide sequence of the gene encoding infectious laryngotracheitis virus glycoprotein B, Virology, 184, pp. 404-410, (1991); 
Kotiw M., Wilks C.R., May J.T., The effect of serial in vivo passage on the expression of virulence and DNA stability of an infectious laryngotracheitis virus strain of low virulence, Vet. Microbiol., 45, pp. 71-80, (1995); 
Lehman J.R., Weigel R.M., Hall W.F., Taft A.C., Eradication of pseudorabies virus from 3 large swine herds achieved by management intervention and use of a vaccine with a deletion for glycoprotein I, J. Am. Vet. Med. Assoc., 205, pp. 1581-1587, (1994); 
Leib D.A., Bradbury J.M., Hart C.A., McCarthy K., Genome isomerism in 2 alphaherpesviruses: Herpesvirus saimiri-1 (Herpesvirus tamarinus) and avian infectious laryngotracheitis virus, Arch. Virol., 93, pp. 287-294, (1987); 
Luschow D., Werner O., Mettenleiter T.C., Fuchs W., Protection of chickens from lethal avian influenza A virus infection by live-virus vaccination with infectious laryngotracheitis virus recombinants expressing the hemagglutinin (H5) gene, Vaccine, 19, pp. 4249-4259, (2001); 
Mettenleiter T.C., Molecular biology of pseudorabies (Aujeszky's disease) virus, Comp. Immunol. Microbiol. Infect. Dis., 14, pp. 151-163, (1991); 
Ndifuna A., Waters A.K., Zhou M., Collisson E.W., Recombinant nucleocapsid protein is potentially an inexpensive, effective serodiagnostic reagent for infectious bronchitis virus, J. Virol. Methods, 70, pp. 37-44, (1998); 
Okamura H., Sakaguchi M., Honda T., Taneno A., Matsuo K., Yamada S., Construction of recombinant infectious laryngotracheitis virus expressing the LacZ gene of E. coli with thymidine kinase gene, J. Vet. Med. Sci., 56, pp. 799-801, (1994); 
Ro L.H., Lai S.S., Hwang W.L., Chou H.H., Huang J.N., Chang E.L., Yang H.L., Cloning and expression of an antigenic domain of glycoprotein gE of pseudorabies virus in Escherichia coli and its use as antigen in diagnostic assays, Am. J. Vet. Res., 56, pp. 555-561, (1995); 
Schnitzlein W.M., Winans R., Ellsworth S., Tripathy D.N., Generation of thymidine kinase-deficient mutants of infectious laryngotracheitis virus, Virology, 209, pp. 304-314, (1995); 
Sohn M.J., Lee M.E., Park H.S., Nham S.U., Lee Y.I., Overexpression and purification of human immunodeficiency virus type 1 env derived epitopes in Escherichia coli, J. Biotechnol., 45, pp. 211-216, (1996); 
Warnes A., Fooks A.R., Stephenson J.R., Production of measles nucleoprotein in different expression systems and its use as a diagnostic reagent, J. Virol. Methods, 45, pp. 257-268, (1994); 
Wild M.A., Cook S., Cochran M., A genomic map of infectious laryngotracheitis virus and the sequence and organization of genes present in the unique short and flanking regions, Virus Genes, 12, pp. 107-116, (1996); 
Wu C.L., Leu T.S., Chang T.T., Shiau A.L., Hepatitis C virus core protein fused to hepatitis B virus core antigen for serological diagnosis of both hepatitis C and hepatitis B infections by ELISA, J. Med. Virol., 57, pp. 104-110, (1999); 
York J.J., Fahey K.J., Humoral and cell-mediated immune responses to the glycoproteins of infectious laryngotracheitis herpesvirus, Arch. Virol., 115, pp. 289-297, (1990); 
York J.J., Sonza S., Brandon M.R., Fahey K.J., Antigens of infectious laryngotracheitis herpesvirus defined by monoclonal antibodies, Arch. Virol., 115, pp. 147-162, (1990); 
Ziemann K., Mettenleiter T.C., Fuchs W., Gene arrangement within the unique long genome region of infectious laryngotracheitis virus is distinct from that of other alphaherpesviruses, J. Virol., 72, pp. 847-852, (1998); 
Ziemann K., Mettenleiter T.C., Fuchs W., Infectious laryngotracheitis herpesvirus expresses a related pair of unique nuclear proteins which are encoded by split genes located at the right end of the UL genome region, J. Virol., 72, pp. 6867-6874, (1998)#FRF#
